Tocilizumab-aazg for Hemorrhage: Reduction of Ischemic Vascular Events
Clinical trial NCT06863480 · RECRUITING
Trial details
- NCT number
- NCT06863480
- Sponsor
- University of Florida
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-02
- Primary completion
- 2028-07-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.